Skip to content
Home/Companies/Pharma/DOC Generici (ICG)

DOC Generici (ICG)

Pharma·Italy·Exited 2022·Held 3yr
Entry
2019
Hold
3yr
Exit
2022

Who owns DOC Generici (ICG)?

DOC Generici (ICG) is an Italian Pharma company, currently owned by TPG Europe since 2022. It changed hands in 2022, when ICG sold.

Hand-verified · updated 2026-09-30

Open JSON · CC-BY
ICG
Most recent investor
ICG
ICG Europe Fund VII · 2018 · Mezzanine
2 ownership periods · full history below

Key facts

HQItaly
SectorPharma
StatusAcquired

Ownership history

2 ownership periods

Active
Currently held by TPG Europe since 2022.
ICG
ICGExited 2022
2019 · 2022(3yr) · ICG Europe Fund VII · 2018 · Mezzanine
Secondary · to TPG

ICG sold DOC Generici (ICG) to TPG in 2022 after 3 years.

2022 · present(4yr) · TPG Europe Portfolio · Buyout

Questions

Who owns DOC Generici (ICG)?

DOC Generici (ICG) is currently owned by TPG Europe, through ICG Europe Fund VII, since 2022.

When did TPG Europe acquire DOC Generici (ICG)?

TPG Europe acquired DOC Generici (ICG) in 2022.

Who did DOC Generici (ICG) sell to?

ICG sold DOC Generici (ICG) to TPG in 2022 (Secondary).

Who has owned DOC Generici (ICG) over time?

DOC Generici (ICG) has been through 2 private-equity ownership periods: ICG · via ICG Europe Fund VII · 2019–2022 · sold to TPG · (Secondary); TPG Europe · since 2022.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue